Departments, HSCD

Medicine & Life Sciences

1. Sleep 100%
2. Women's Health 52%
3. Heart Failure 41%
4. Breast Neoplasms 37%
5. Myocardial Infarction 34%
6. Non-alcoholic Fatty Liver Disease 32%
7. Lung 30%
8. Mortality 29%
9. Diet 28%
10. Sleep Initiation and Maintenance Disorders 26%
11. Therapeutics 24%
12. Exercise 23%
13. Health 22%
14. Cancer Survivors 21%
15. Aerosols 21%
16. Confidence Intervals 21%
17. Hispanic Americans 20%
18. Neoplasms 19%
19. Biomarkers 19%
20. Pharmaceutical Preparations 19%
21. Powders 19%
22. Obstructive Sleep Apnea 18%
23. Liver 18%
24. Survival 18%
25. Obesity 17%
26. Healthy Diet 16%
27. Proteins 16%
28. Vegetables 15%
29. Pulmonary Surfactant-Associated Protein A 15%
30. Lung Transplantation 15%
31. Dry Powder Inhalers 15%
32. Cardiovascular Diseases 14%
33. Fats 14%
34. Population 14%
35. Colorectal Neoplasms 14%
36. Incidence 13%
37. Pressure 13%
38. Genes 13%
39. Sleep Apnea Syndromes 13%
40. Inhalation 13%
41. Body Mass Index 13%
42. Weights and Measures 13%
43. Odds Ratio 13%
44. Food 12%
45. Colonic Neoplasms 12%
46. Messenger RNA 12%
47. Epithelial Cells 12%
48. Coronary Artery Disease 11%
49. Brain 11%
50. African Americans 11%
51. Fruit 11%
52. Blood Pressure 11%
53. myosin-binding protein C 11%
54. Inflammation 10%
55. Carotenoids 10%
56. Overweight 10%
57. Dietary Fats 10%
58. Randomized Controlled Trials 10%
59. Coronary Vessels 10%
60. Microbiota 10%
61. Adult Respiratory Distress Syndrome 10%
62. Cystic Fibrosis 9%
63. Medicine 9%
64. Kidney 9%
65. Xenobiotics 9%
66. Diet Therapy 9%
67. Spironolactone 9%
68. In Vitro Techniques 9%
69. Clinical Trials 9%
70. Neurons 9%
71. Stroke 9%
72. Antihypertensive Agents 9%
73. Guidelines 9%
74. Asthma 9%
75. Depression 9%
76. Atrial Fibrillation 9%
77. Gene Expression 9%
78. Weight Loss 9%
79. Equipment and Supplies 9%
80. constitutive androstane receptor 9%
81. Heart 9%
82. Hypertension 9%
83. Nucleus Accumbens 8%
84. Neuronal Plasticity 8%
85. Nanoparticles 8%
86. Neural Stem Cells 8%
87. Hospitalization 8%
88. Chronic Obstructive Pulmonary Disease 8%
89. Enzymes 8%
90. Oxidoreductases 8%
91. Placebos 8%
92. European Continental Ancestry Group 8%
93. Observational Studies 8%
94. Genome-Wide Association Study 8%
95. Pulmonary Hypertension 8%
96. Alcohols 8%
97. Choline 8%
98. Coronavirus 8%
99. Hormones 8%
100. Microfluidics 7%